Quantcast

Latest Stem cells Stories

2014-05-14 08:31:21

RICHMOND, Calif., May 14, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that data from clinical, preclinical and research-stage programs focused on the development of ZFP Therapeutics(®) will be presented at the 17th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT). Fourteen oral and poster presentations, given by Sangamo scientists and their academic collaborators, will detail data from Sangamo's therapeutic and research programs...

2014-05-13 12:34:16

NEW YORK, May 13, 2014 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous stromal vascular fraction cells (SVFCs) derived from the blood vessels found in adipose tissue, announced today that Merril Hoge, former star NFL player and an on-air analyst for ESPN, has joined its Board of Advisors. According to Merril Hoge, "After tearing a ligament in my elbow I tried to rehab it to avoid...

2014-05-13 08:31:54

SHENZHEN, China, May 13, 2014 /PRNewswire/ -- Chinese researchers have recently published new findings in Arthritis Research & Therapy, a top peer-reviewed journal in the field of systemic autoimmune rheumatic diseases, regarding the safety and effectiveness of umbilical cord (UC) derived mesenchymal stem cells (MSCs) in treating 40 patients with severe and refractory Systemic Lupus Erythematosus (SLE). The recent forty patient multi-center study was undertaken to assess the...

2014-05-12 23:06:20

STEMCELL Technologies Inc. has just released NEW MesenCult™ Proliferation Kit with MesenPure™ (Mouse), a novel cell culture medium to advance research on mouse mesenchymal stem and progenitor cells (MSCs). Vancouver, British Columbia (PRWEB) May 12, 2014 STEMCELL Technologies Inc. has just released NEW MesenCult™ Proliferation Kit with MesenPure™ (Mouse), a novel cell culture medium to advance research on mouse mesenchymal stem and progenitor cells (MSCs). When added to...

2014-05-12 16:28:31

Partnership between two preeminent institutions serving the Midwest and Northeast will bring synergies in blood and laboratory services, medical programs, cell therapies and research KANSAS CITY, Mo. and NEW YORK, May 12, 2014 /PRNewswire-USNewswire/ -- Community Blood Center of Greater Kansas City (CBC) and New York Blood Center (NYBC) announced today that they are combining their operations to create one of the leading blood centers serving patients and hospitals in the Northeast...

'Heart Disease-On-A-Chip' Made From Patient Stem Cells
2014-05-12 03:22:55

[ Watch The Video: Cardiac Tissue Contractile Strength Differences Shown Using “Heart-On-A-Chip” ] Harvard University Harvard scientists have merged stem cell and 'organ-on-a-chip' technologies to grow, for the first time, functioning human heart tissue carrying an inherited cardiovascular disease. The research appears to be a big step forward for personalized medicine, as it is working proof that a chunk of tissue containing a patient's specific genetic disorder can be replicated...

2014-05-12 08:33:28

ROCKVILLE, Md., May 12, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported its financial results for the three months ended March 31, 2014 and provided a business and clinical update. "During the first quarter of 2014, we continued to advance the NSI-566 cell therapy platform through human clinical trials. We have completed treatment of the fourth cohort in our ALS Phase II escalating dose trials, in collaboration with our sites at University of Michigan, Emory and...

2014-05-12 08:33:04

SAN DIEGO, May 12, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) today announced that the Company's Excellagen(®) flowable dermal matrix in combination with Orbsen Therapeutics' mesenchymal stromal stem cell therapy Cyndacel-M(TM) has been selected for clinical evaluation in a Phase 1b safety study for the potential treatment of chronic diabetic wounds to be funded by the European Union under EU Framework 7 (FP7). The project, known by the...

2014-05-12 08:32:37

DUBLIN, May 12, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/sqctb8/stem_cell_therapy) has announced the addition of the "Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The...

2014-05-09 23:09:06

Tom McManus, former professional football player with Jacksonville Jaguars, is teaming up with SmartChoice® Stem Cell Institute as a spokesperson to promote awareness of benefits and success of Adult Stem Cell procedures as non-surgical treatment for sports injuries, arthritis, joint and back pain. Jacksonville, FL (PRWEB) May 09, 2014 Tom McManus, former professional football player with the Jacksonville Jaguars is teaming up with SmartChoice® Stem Cell Institute as a...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'